E-Cadherin is Dispensable to Maintain Langerhans Cells in the Epidermis.


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
01 2020
Historique:
received: 27 02 2019
revised: 28 05 2019
accepted: 17 06 2019
pubmed: 2 7 2019
medline: 16 7 2020
entrez: 2 7 2019
Statut: ppublish

Résumé

The cell adhesion molecule E-cadherin is a major component of adherens junctions and marks Langerhans cells (LC), the only dendritic cell (DC) population of the epidermis. LC form a dense network and attach themselves to the surrounding keratinocytes via homophilic E-cadherin binding. LC activation, mobilization, and migration require a reduction in LC E-cadherin expression. To determine whether E-cadherin plays a role in regulating LC homeostasis and function, we generated CD11c-specific E-cadherin knockout mice (CD11c-Ecad

Identifiants

pubmed: 31260672
pii: S0022-202X(19)31799-3
doi: 10.1016/j.jid.2019.06.132
pii:
doi:

Substances chimiques

CD11c Antigen 0
Cadherins 0
Imiquimod P1QW714R7M

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-142.e3

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Anna Brand (A)

Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.

Nathalie Diener (N)

Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.

Sonja P Zahner (SP)

Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA.

Christoph Tripp (C)

Division of Experimental Dermatology, Department of Dermatology, Venereology & Allergology, Medical University of Innsbruck, Innsbruck, Austria.

Ronald A Backer (RA)

Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.

Khalad Karram (K)

Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.

Aimin Jiang (A)

Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York, USA.

Ira Mellman (I)

Research Oncology, Genentech, South San Francisco, California, USA.

Patrizia Stoitzner (P)

Division of Experimental Dermatology, Department of Dermatology, Venereology & Allergology, Medical University of Innsbruck, Innsbruck, Austria.

Björn E Clausen (BE)

Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany. Electronic address: bclausen@uni-mainz.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH